Power Leaves Completes Reverse Takeover Of Atmofizer Technologies Inc. Shares To Commence Trading On The CSE
| Holder group | Resulting Issuer Shares | % of outstanding |
| Former PLC shareholders (including shares issued on exchange of subscription receipts) | 204,900,212 | ~97.05% |
| Former Atmofizer shareholders (post-Consolidation) | 4,323,999 | ~2.05% |
| Holders of convertible debentures | 1,902,565 | ~0.90% |
The Resulting Issuer also has 1,215,296 finder warrants outstanding and 15,739,241 warrants outstanding, inclusive of 1,215,296 warrants issuable upon the exercise of finder warrants.
Concurrent Financing
In connection with the Transaction, PLC completed a non-brokered subscription receipt financing in three tranches - on March 13, 2026, April 30, 2026 and August 7, 2026 - issuing an aggregate of 12,621,380 subscription receipts at a price of US$0.25 per subscription receipt for aggregate gross proceeds of US$3,155,345 (the " Concurrent Financing ").
Immediately prior to the closing of the Transaction, the escrowed proceeds of the Concurrent Financing were released and each subscription receipt was automatically exchanged for one PLC unit, comprised of one PLC common share and one PLC warrant. Each replacement warrant of the Resulting Issuer is exercisable to acquire one Resulting Issuer Share at a price of US$0.30 until August 31, 2028, subject to acceleration in accordance with its terms.
Net proceeds of approximately US$3,025,000 will be applied to manufacturing equipment, quality systems and certifications, sales and marketing, product research and development, Transaction expenses and working capital and general corporate purposes.
Convertible Debenture Financing
On June 16, 2026 and July 22, 2026, the Company completed non-brokered private placements of unsecured, non-interest bearing convertible debentures for aggregate gross proceeds of C$660,000. The net proceeds were advanced to PLC by way of unsecured promissory notes to fund working capital, transaction expenses and general corporate purposes in advance of closing. On closing of the Transaction, the Company elected to convert the convertible debentures into units of the Resulting Issuer comprised of one Resulting Issuer Share and one Resulting Issuer warrant on terms economically equivalent to those of the Concurrent Financing and as a result, 1,902,565 units of the Resulting Issuer were issued to debenture holders.
Directors and Officers
Effective on closing, all directors and officers of Atmofizer resigned and were replaced by nominees of PLC. The board and management of the Resulting Issuer are as follows:
- Pat McCutcheon - Chief Executive Officer, Director and Chair of the Board Ahmed Shehata - President and Director Chris Hobbs - Chief Financial Officer Javier Giraldo - Independent Director Pierre Pelletier - Independent Director Inna Kaplun - Independent Director
Mr. McCutcheon is a co-founder of MediPharm Labs, where he served as President and Chief Executive Officer and led its growth into one of the largest cannabis extraction companies in the world, overseeing the construction of two GMP pharma-certified manufacturing facilities exporting to seven countries and leading capital raises totalling over $270 million.
The board of directors and management of the Resulting Issuer thank Olivier Centner and the outgoing directors and officers of Atmofizer for their service and their work in bringing the Transaction to completion.
Escrow and Lock-Up Arrangements
In accordance with section 8.8 of CSE Policy 8 - Fundamental Changes and Changes of Business, an aggregate of 23,979,555 Resulting Issuer Shares held by principal insiders of the Resulting Issuer have been placed into escrow with Odyssey Trust Company, as escrow agent, and will be released as to 10% on the listing date and 15% at each of 6, 12, 18, 24 and 30 months following the listing date, with the balance released 36 months following the listing date.
In addition, founders, directors and officers of PLC and certain PLC shareholders who acquired their shares below specified price thresholds have entered into voluntary lock-up agreements for a period of 12 months following closing, subject to customary exceptions and an early release trigger tied to the Resulting Issuer Shares achieving a volume weighted average trading price of at least US$0.45 for five consecutive trading days.
Further Information
Additional information regarding the Transaction, the Resulting Issuer and its business is contained in the Company's Form 2A Listing Statement dated August 28, 2026, a copy of which is available under the Company's profile on SEDAR+ at and on the CSE's website.
Advisors
Wildeboer Dellelce LLP acted as legal counsel to Power Leaves Corp. Gowling WLG (Canada) LLP acted as legal counsel to Atmofizer Technologies Inc.
About Power Leaves Holdings Corp.
The Company is breaking the monopoly on the supply of coca leaf extract and ushering in a new Age of Coca. Through an exclusive licence agreement with the Nasa Indigenous Community of the Indigenous Reserve of Calderas in Colombia, the Company has developed the first-ever legal Colombian supply chain for decocainized coca extract to supply the global food and beverage markets. Its infrastructure comprises three purpose-built facilities in the Neiva region of Colombia - a manufacturing campus for extraction and decocainization, an INVIMA-registered research and development facility, and an FDA-registered formulation and packaging facility. The Company is commercializing two proprietary products, Coca Extract and Coca Essence, as novel, all-natural ingredients for the global food and beverage market. For more information, visit .
For additional information, please contact:
Power Leaves Holdings Corp.
Pat McCutcheon, Chief Executive Officer
+1 (705) 333-0526
...
Cautionary Notes
This press release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could," "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements in this press release include, but are not limited to: statements relating to the listing and commencement of trading of the Resulting Issuer Shares on the CSE and the timing thereof; the trading symbol of the Resulting Issuer; the satisfaction of the CSE's remaining listing conditions; the anticipated use of proceeds of the Concurrent Financing; the Resulting Issuer's plans to scale production capacity, implement quality systems and obtain certifications; the commencement of product distribution and the development of the Resulting Issuer's commercial pipeline; the duration and release of escrow and lock-up restrictions; and the composition of the board of directors and management of the Resulting Issuer. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the Resulting Issuer's dependence on its licence agreement with, and relationship with, the Nasa Indigenous community; reliance on licences and authorizations to operate in Colombia; supply chain, agricultural and seasonality risks; the concentration of operations in a single region of Colombia; import and distribution restrictions; the Resulting Issuer's ability to expand production capacity and complete required certifications and quality audits; the need for additional financing; and the delay or failure to receive any necessary regulatory or exchange approvals, including the approval of the CSE. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Except as required by law, the Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
Unless otherwise indicated, all dollar amounts in this press release are expressed in United States dollars.
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of this release.
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit
Source: Power Leaves Holdings Corp.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment